Gabriela Hobbs

ORCID: 0000-0002-0199-9333 · 1 paper in corpus

editorial 2022

Treating Anemic Patients With Myelofibrosis in the New Janus Kinase Inhibitor Era: Current Evidence and Real-world Implications

·doi:10.1097/hs9.0000000000000778

Anemia is a prevalent and burdensome clinical manifestation of myelofibrosis (MF) with a complex etiology. Most MF patients are anemic within 1 year of diagnosis, and nearly all become dependent on red blood cell transfusions over time.1 An…